Technology  September 12, 2014

Array BioPharma hires Sandor as chief medical officer

BOULDER — Array BioPharma Inc. has hired Dr. Victor Sandor as chief medical officer, replacing Dr. Michael Needle, who is leaving the company to pursue other opportunities.

Boulder-based Array (Nasdaq: ARRY) develops and commercializes drugs that treat cancer.

Sandor will be responsible for leading clinical, medical and regulatory strategy and operations across the Array portfolio, including binimetinib, a drug in Phase 3 trials to treat ovarian cancer and melanoma, and filanesib, a drug for multiple myeloma.

SPONSORED CONTENT

Business Cares: March 2024

WomenGive, a program of United Way of Larimer County, was started in Larimer County in 2006 as an opportunity for women in our community to come together to help other women.

Sandor has experience working at biopharmaceutical and pharmaceutical companies, including Incyte Corp. Biogen Idec and AstraZeneca.

“Dr. Sandor’s leadership, experience and vision will strengthen our clinical development efforts as we advance our late-stage, wholly owned assets toward commercialization,” Ron Squarer, Array’s chief executive, said in a prepared statement.

Sandor received his medical degree from McGill University in Montreal, Canada, and completed his Fellowship in Medical Oncology at the National Institutes of Health in Bethesda, Md.

BOULDER — Array BioPharma Inc. has hired Dr. Victor Sandor as chief medical officer, replacing Dr. Michael Needle, who is leaving the company to pursue other opportunities.

Boulder-based Array (Nasdaq: ARRY) develops and commercializes drugs that treat cancer.

Sandor will be responsible for leading clinical, medical and regulatory strategy and operations across the Array portfolio, including binimetinib, a drug in Phase 3 trials to treat ovarian cancer and melanoma, and filanesib, a drug for multiple myeloma.

Sandor has experience working at biopharmaceutical and pharmaceutical companies, including Incyte Corp. Biogen Idec and AstraZeneca.

“Dr. Sandor’s leadership, experience and vision will strengthen our clinical development efforts as…

Sign up for BizWest Daily Alerts